Green tea extract rich in epigallocatechin-3-gallate prevents fatty liver by AMPK activation via LKB1 in mice fed a high-fat diet

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Santamarina, Aline B ^a   Oliveira, Juliana L ^a   Silva, Fernanda P ^a   Carnier, June ^a   Mennitti, Laís V ^a   Santana, Aline A ^a   De Souza, Gabriel H I ^b   Ribeiro, Eliane B ^a   Do Nascimento, Cláudia M Oller ^a   Lira, Fábio S ^c   Oyama, Lila M ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO JUDAS TADEU UNIVERSITY   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN; ADIPONECTIN RECEPTOR 2; BINDING PROTEIN; CARBOHYDRATE RESPONSE ELEMENT BINDING PROTEIN; EPIGALLOCATECHIN GALLATE; FAS ANTIGEN; GREEN TEA EXTRACT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PLACEBO; PROTEIN KINASE LKB1; SIRTUIN 1; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; CATECHIN; PLANT EXTRACT; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, MOUSE; TEA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; LIPID ANALYSIS; LIPID DIET; LIPOGENESIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PROPHYLAXIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUPPLEMENTATION; TEA; WEIGHT GAIN; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BODY WEIGHT; CHEMISTRY; DRUG EFFECTS; FATTY LIVER; METABOLISM; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CATECHIN; DIET, HIGH-FAT; ENZYME ACTIVATION; FATTY LIVER; MALE; MICE; PLANT EXTRACTS; PROTEIN-SERINE-THREONINE KINASES; TEA;

EID: 84951075233     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141227     Document Type: Article

References (90)

1. Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011; 29: 415-45. doi: 10.1146/annurev-immunol-031210-101322 PMID: 21219177
2. Darnton-Hill I, Nishida C, James W. A life course approach to diet, nutrition and the prevention of chronic diseases. Public Health Nutr. 2007; 7: 101-121. doi: 10.1079/PHN2003584
3. Charlton MR, Burns JM, Pedersen R, Watt KD, Heimbach JK, Dierkhising R. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. Elsevier Inc.; 2011; 141: 1249-53. doi: 10.1053/j.gastro.2011.06.061
4. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-1801. doi: 10.1172/JCI29069 PMID: 16823477
5. Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013; 7: 14-24. doi: 10.1007/s11684-013-0262-6 PMID: 23471659
6. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005; 115: 1343-1351. doi: 10.1172/JCI200523621 PMID: 15864352
7. Vigouroux C, Caron-Debarle M, Le Dour C, Magré J, Capeau J. Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity. Int J Biochem Cell Biol. Elsevier Ltd; 2011; 43: 862-76. doi: 10.1016/j.biocel.2011.03.002 PMID: 21392585
8. Byrne CD. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease. Proc Nutr Soc. 2013; 1-8.
9. Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann N Y Acad Sci. 2013; 1281: 106-22. doi: 10.1111/nyas.12016 PMID: 23363012
10. Shearn CT, Smathers RL, Jiang H, Orlicky DJ, Maclean KN, Petersen DR. Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of earlystage ethanol-mediated steatosis. J Nutr Biochem. Elsevier B.V.; 2013; 1: 1-10. doi: 10.1016/j.jnutbio. 2012.12.002
11. Yang Z, Kahn BB, Shi H, Xue B-Z. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 2010; 285: 19051-9. doi: 10. 1074/jbc.M110.123620 PMID: 20421294
12. Duval C, Thissen U, Keshtkar S, Accart B, Stienstra R, Boekschoten MV, et al. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57Bl/6 mice. Diabetes. 2010; 59: 3181-3191. doi: 10.2337/db10-0224 PMID: 20858684
13. Seo H-Y, Kim M-K, Jung Y-A, Jang BK, Yoo E-K, Park K-G, et al. Clusterin decreases hepatic SREBP-1c expression and lipid accumulation. Endocrinology. 2013; 154: 1722-30. doi: 10.1210/en.2012-2009 PMID: 23515283
14. Blagih J, Krawczyk CM, Jones RG. LKB1 and AMPK: central regulators of lymphocyte metabolism and function. Immunol Rev. 2012; 249: 59-71. doi: 10.1111/j.1600-065X.2012.01157.x PMID: 22889215
15. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009; 9: 563-575. doi: 10.1038/nrc2676 PMID: 19629071
16. Hou X, Xu S, Maitland-Toolan K, Sato K, Jiang B, Ido Y, et al. SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem. 2008; 283: 20015-20026. doi: 10. 1074/jbc.M802187200 PMID: 18482975
17. Gan R-Y, Li H-B. Recent Progress on Liver Kinase B1 (LKB1): Expression, Regulation, Downstream Signaling and Cancer Suppressive Function. Int J Mol Sci. 2014; 15: 16698-16718. doi: 10.3390/ ijms150916698 PMID: 25244018
18. Banerjee S, Ghoshal S, Porter TD. Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice. Nutr Res. 2012; 32: 985-990. doi: 10.1016/j.nutres.2012.10.005 PMID: 23244544
19. Hasenour CM, Berglund ED, Wasserman DH. Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver. Mol Cell Endocrinol. Elsevier Ireland Ltd; 2013; 366: 152-62. doi: 10.1016/j.mce.2012.06.018 PMID: 22796337
20. Song C-Y, Shi J, Zeng X, Zhang Y, Xie W-F, Chen Y-X. Sophocarpine alleviates hepatocyte steatosis through activating AMPK signaling pathway. Toxicol In Vitro. 2013; 27: 1065-71. doi: 10.1016/j.tiv. 2013.01.020 PMID: 23395669
21. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. 2004;114. doi: 10. 1172/JCI200422422.The
22. Iizuka K. Recent progress on the role of ChREBP in glucose and lipid metabolism. Endocr J. 2013; 60: 543-55. doi: 10.1507/endocrj PMID: 23604004
23. O'Neill HM, Holloway GP, Steinberg GR. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity. Mol Cell Endocrinol. Elsevier Ireland Ltd; 2013; 366: 135-51. doi: 10.1016/j.mce.2012.06.019 PMID: 22750049
24. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr. 2008; 138: 1677-1683. doi: 10.1016/j.bbi.2008.05.010 PMID: 18716169
25. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, et al. Novel insights of dietary polyphenols and obesity. J Nutr Biochem. Elsevier Inc.; 2014; 25: 1-18. doi: 10.1016/j.jnutbio.2013.09.001 PMID: 24314860
26. Costa S, Utan A, Cervellati R, Speroni E, Guerra MC. Catechins: natural free-radical scavengers against ochratoxin A-induced cell damage in a pig kidney cell line (LLC-PK1). Food Chem Toxicol. 2007; 45: 1910-7. doi: 10.1016/j.fct.2007.04.008 PMID: 17548142
27. Xiao J, Ho CT, Liong EC, Nanji A, Leung TM, Lau TYH, et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/ SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr. 2014; 53: 187-199. doi: 10.1007/ s00394-013-0516-8 PMID: 23515587
28. Muramatsu K, Fukuyo M, Hara Y. Effect of green tea catechins on plasma cholesterol level in cholesterol-fed rats. J Nutr Sci Vitaminol (Tokyo). 1986; 32: 613-622. doi: 10.3177/jnsv.32.613
29. Sabu MC, Smitha K, Kuttan R. Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol. 2002; 83: 109-116. doi: 10.1016/S0378-8741(02)00217-9 PMID: 12413715
30. Davaatseren M, Hur HJ, Yang HJ, Hwang JT, Park JH, Kim HJ, et al. Taraxacum official (dandelion) leaf extract alleviates high-fat diet-induced nonalcoholic fatty liver. Food Chem Toxicol. Elsevier Ltd; 2013; 58: 30-36. doi: 10.1016/j.fct.2013.04.023 PMID: 23603008
31. Shen L, Xiong Y, Wang DQ-H, Howles P, Basford JE, Wang J, et al. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res. 2013; 54: 1430-8. doi: 10. 1194/jlr.M035907 PMID: 23434611
32. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. Elsevier Inc.; 2011; 14: 612-22. doi: 10.1016/j.cmet.2011.10.002
33. Zang M, Xu S, Maitland-Toolan K, Zuccollo A, Hou X, Jiang B, et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes. 2006; 55: 2180-91. doi: 10.2337/db05-1188 PMID: 16873680
34. Latif R. Chocolate/cocoa and human health: a review. Neth J Med. 2013; 71: 63-8. Available: http:// www.ncbi.nlm.nih.gov/pubmed/23462053 PMID: 23462053
35. Kobayashi-Hattori K, Mogi A, Matsumoto Y, Takita T. Effect of caffeine on the body fat and lipid metabolism of rats fed on a high-fat diet. Biosci Biotechnol Biochem. 2005; 69: 2219-2223. doi: 10.1271/bbb. 69.2219 PMID: 16306706
36. Kurimoto Y, Shibayama Y, Inoue S, Soga M, Takikawa M, Ito C, et al. Black soybean seed coat extract ameliorates hyperglycemia and insulin sensitivity via the activation of AMP-activated protein kinase in diabetic mice. J Agric Food Chem. 2013; 61: 5558-5564. doi: 10.1021/jf401190y PMID: 23683106
37. BRAZIL C. Diretriz brasileira para o cuidado e a utilização de animais para fins científicos e didáticos [Internet]. Brasília DF-Brazil; 2013 pp. 1-50. Available: http://www.cobea.org.br/arquivo/download? ID-ARQUIVO=20
38. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr. 1993; 123: 1939-51. Available: http://www.ncbi.nlm.nih.gov/pubmed/8229312 PMID: 8229312
39. Stansbie D, Denton RM, Bridges BJ, Pask HT, Randle PJ. Regulation of Pyruvate Dehydrogenase and Pyruvate Dehydrogenase Phosphate Activity in Rat Epididymal Fat-Pads. Biochem J. 1976; 154: 225-236. PMID: 6018
40. Oller do Nascimento CM, Williamson DH. Evidence for conservation of dietary lipid in the rat during lactation and the immediate period after removal of the litter. Decreased oxidation of oral [1-14C]triolein. Biochem J. 1986; 239: 233-236. PMID: 3099779
41. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18: 499-502. doi: 10.1177/107424840501000106 PMID: 4337382
42. An R, Burd N. Change in daily energy intake associated with pairwise compositional change in carbohydrate, fat and protein intake among US adults, 1999-2010. Public Health Nutr. 2014; 1-10.
43. Carillon J, Romain C, Bardy G, Fouret G, Feillet-Coudray C, Gaillet S, et al. Cafeteria diet induces obesity and insulin resistance associated with oxidative stress but not with inflammation: improvement by dietary supplementation with a melon superoxide dismutase. Free Radic Biol Med. Elsevier; 2013; 65: 254-61. doi: 10.1016/j.freeradbiomed.2013.06.022 PMID: 23792771
44. Turner N, Kowalski GM, Leslie SJ, Risis S, Yang C, Lee-Young RS, et al. Distinct patterns of tissuespecific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding. Diabetologia. 2013; 56: 1638-48. doi: 10.1007/s00125-013-2913-1 PMID: 23620060
45. Buettner R, Parhofer KG, Woenckhaus M, Wrede CE, Kunz-Schughart LA, Schölmerich J, et al. Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006;
46. Martins SV, Lopes P, Alfaia CM, Rodrigues PO, Alves SP, Pinto RM, et al. Serum adipokine profile and fatty acid composition of adipose tissues are affected by conjugated linoleic acid and saturated fat diets in obese Zucker rats. Br J Nutr. 2010; 103: 869-78. doi: 10.1017/S000711450999256X PMID: 19878618
47. Chen Y, Cheung C, Reuhl K. Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice. J Agric Food Chem. 2011; 59: 11862-71. doi: 10.1021/jf2029016 PMID: 21932846
48. Zhou J, Farah BL, Sinha RA, Wu Y, Singh BK, Bay B-H, et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One. 2014; 9: e87161. doi: 10.1371/journal.pone.0087161 PMID: 24489859
49. Cunha CA, Lira FS, Rosa Neto JC, Pimentel GD, Souza GIH, da Silva CMG, et al. Green tea extract supplementation induces the lipolytic pathway, attenuates obesity, and reduces low-grade inflammation in mice fed a high-fat diet. Mediators Inflamm. 2013; 2013: 635470. doi: 10.1155/2013/ 635470 PMID: 23431242
50. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: a literature review. Chin Med. 2010; 5: 13 doi: 10.1186/1749-8546-5-13 PMID: 20370896
51. Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, Howe PRC. Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr. 2007; 26: 396S-402S. Available: http://www.ncbi.nlm.nih.gov/ pubmed/17906193 PMID: 17906193
52. Lin J-K, Lin-Shiau S-Y. Mechanisms of hypolipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res. 2006; 50: 211-7. doi: 10.1002/mnfr.200500138 PMID: 16404708
53. Ma Q, Kim EY, Lindsay EA, Han O. Bioactive Dietary Polyphenols Inhibit Heme Iron Absorption in a Dose-Dependent Manner in Human Intestinal Caco-2 Cells. J Food Sci. 2011;76. doi: 10.1111/j.1750-3841.2011.02184.x
54. Kim EY, Pai TK, Han O. Effect of bioactive dietary polyphenols on zinc transport across the intestinal caco-2 cell monolayers. J Agric Food Chem. 2011; 59: 3606-3612. doi: 10.1021/jf104260j PMID: 21410257
55. Lambert JD, Kennett MJ, Sang S, Reuhl KR, Ju J, Yang CS. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol. 2010; 48: 409-416. doi: 10.1016/j.fct.2009.10.030 PMID: 19883714
56. Bollheimer LC, Buettner R, Pongratz G, Brunner-Ploss R, Hechtl C, Banas M, et al. Sarcopenia in the aging high-fat fed rat: A pilot study for modeling sarcopenic obesity in rodents. Biogerontology. 2012; 13: 609-620. doi: 10.1007/s10522-012-9405-4 PMID: 23065329
57. Kim TN, Choi KM. The implications of sarcopenia and sarcopenic obesity on cardiometabolic disease. J Cell Biochem. 2014; n/a-n/a.
58. De Rosa E, Santarpia L, Marra M, Sammarco R, Amato V, Onufrio M, et al. Preliminary evaluation of the prevalence of sarcopenia in obese patients from Southern Italy. Nutrition. 2014;
59. Fellner C, Schick F, Kob R, Hechtl C, Vorbuchner M, Büttner R, et al. Diet-Induced and Age-Related Changes in the Quadriceps Muscle: MRI and MRS in a Rat Model of Sarcopenia. Gerontology. 2014; 60: 530-538. doi: 10.1159/000360289 PMID: 24924578
60. Ratto E, Leoncini G, Viazzi F, Vaccaro V, Parodi A, Falqui V, et al. Metabolic syndrome and cardiovascular risk in primary hypertension. J Am Soc Nephrol. 2006; 17: S120-2. doi: 10.1681/ASN. 2005121328 PMID: 16565234
61. Stanhope KL, Havel PJ. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol. 2008; 19: 16-24. doi: 10. 1097/MOL.0b013e3282f2b24a PMID: 18196982
62. Blachnio-Zabielska A, Baranowski M, Zabielski P, Gorski J. Effect of high fat diet enriched with unsaturated and diet rich in saturated fatty acids on sphingolipid metabolism in rat skeletal muscle. J Cell Physiol. 2010; 225: 786-91. doi: 10.1002/jcp.22283 PMID: 20568228
63. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW. The role of intramuscular lipid in insulin resistance. Acta Physiol Scand. 2003; 178: 373-83. Available: http://www.ncbi.nlm.nih.gov/pubmed/ 16357064 PMID: 12864742
64. Fujimura Y, Sumida M, Sugihara K, Tsukamoto S, Yamada K, Tachibana H. Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor. PLoS One. 2012; 7: e37942. doi: 10.1371/journal. pone.0037942 PMID: 22666419
65. Kim H-S, Quon MJ, Kim J-A. New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol. Elsevier; 2014; 2: 187-195. doi: 10.1016/j.redox.2013.12.022 PMID: 24494192
66. Tachibana H. Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87: 66-80. doi: 10.2183/pjab.87.66 PMID: 21422740
67. Wang C-T, Chang H-H, Hsiao C-H, Lee M-J, Ku H-C, Hu Y-J, et al. The effects of green tea (-)-epigallocatechin-3-gallate on reactive oxygen species in 3T3-L1 preadipocytes and adipocytes depend on the glutathione and 67 kDa laminin receptor pathways. Mol Nutr Food Res. 2009; 53: 349-60. doi: 10. 1002/mnfr.200800013 PMID: 19065584
68. Hong Byun E, Fujimura Y, Yamada K, Tachibana H. TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor. J Immunol. 2010; 185: 33-45. doi: 10.4049/jimmunol.0903742 PMID: 20511545
69. Kao YH, Chang HH, Lee MJ, Chen CL. Tea, obesity, and diabetes. Mol Nutr Food Res. 2006; 50: 188-210. doi: 10.1002/mnfr.200500109 PMID: 16416476
70. Derdemezis CS, Kiortsis DN, Tsimihodimos V, Petraki MP, Vezyraki P, Elisaf MS, et al. Effect of plant polyphenols on adipokine secretion from human SGBS adipocytes. Biochem Res Int. 2011.
71. Shimada M, Mochizuki K, Sakurai N, Goda T. Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats. Biosci Biotechnol Biochem. 2007; 71: 2079-2082. doi: 10.1271/bbb.70174 PMID: 17690452
72. Wu AH, Yu MC, Stanczyk FZ, Tseng C-C, Pike MC. Anthropometric, dietary, and hormonal correlates of serum adiponectin in Asian American women. Nutr Cancer. 2011; 63: 549-557. doi: 10.1080/ 01635581.2011.551986 PMID: 21547847
73. Shafiei MS, Shetty S, Scherer PE, Rockey DC. Adiponectin regulation of stellate cell activation via PPARγ-dependent and-independent mechanisms. Am J Pathol. Elsevier Inc.; 2011; 178: 2690-2699. doi: 10.1016/j.ajpath.2011.02.035 PMID: 21641391
74. Tian C, Ye X, Zhang R, Long J, Ren W, Ding S, et al. Green Tea Polyphenols Reduced Fat Deposits in High Fat-Fed Rats via erk1/2-PPARγ-Adiponectin Pathway. PLoS One. 2013; 8.
75. Liang X, Hu M, Rogers CQ, Shen Z, You M. Role of SIRT1-FoxO1 signaling in dietary saturated fatdependent upregulation of liver adiponectin receptor 2 in ethanol-administered mice. Antioxid Redox Signal. 2011; 15: 425-435. doi: 10.1089/ars.2010.3780 PMID: 21194380
76. Jiang Z, Zhou J, Zhou D, Zhu Z, Sun L, Nanji AA. The Adiponectin-SIRT1-AMPK Pathway in Alcoholic Fatty Liver Disease in the Rat. Alcohol Clin Exp Res. 2015; 39: 424-433. doi: 10.1111/acer.12641 PMID: 25703252
77. Gillum MP, Kotas ME, Erion DM, Kursawe R, Chatterjee P, Nead KT, et al. SirT1 regulates adipose tissue inflammation. Diabetes. 2011; 60: 3235-3245. doi: 10.2337/db11-0616 PMID: 22110092
78. Civitarese AE, Carling S, Heilbronn LK, Hulver MH, Ukropcova B, Deutsch W, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PLoS Med. 2007; 4: 485-494. doi: 10. 1371/journal.pmed.0040076
79. Lee J, Hong S-W, Rhee E-J, Lee W-Y. GLP-1 Receptor Agonist and Non-Alcoholic Fatty Liver Disease. Diabetes Metab J. 2012; 36: 262-7. doi: 10.4093/dmj.2012.36.4.262 PMID: 22950055
80. Shen Z, Liang X, Rogers CQ, Rideout D, You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol. 2010; 298: G364-G374. doi: 10.1152/ajpgi.00456.2009 PMID: 20007851
81. Cantó C, Auwerx J. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol. 2009; 20: 98-105. doi: 10.1097/MOL.0b013e328328d0a4 PMID: 19276888
82. Ceddia RB. The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol Cell Endocrinol. Elsevier Ireland Ltd; 2013; 366: 194-203. doi: 10.1016/j.mce.2012.06.014 PMID: 22750051
83. Zhang W, Zhang X, Wang H, Guo X, Li H, Wang Y, et al. AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes. 2012; 61: 3114-25. doi: 10.2337/db11-1373 PMID: 22829451
84. Viollet B, Guigas B, Leclerc J, Hébrard S, Lantier L, Mounier R, et al. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiol (Oxf). 2009; 196: 81-98. doi: 10.1111/j.1748-1716.2009.01970.x
85. Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, et al. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int J Mol Med. 2008; 21: 507-11. Available: http://www.ncbi.nlm.nih.gov/pubmed/18360697 PMID: 18360697
86. Henriksen BS, Curtis ME, Fillmore N, Cardon BR, Thomson DM, Hancock CR. The effects of chronic AMPK activation on hepatic triglyceride accumulation and glycerol 3-phosphate acyltransferase activity with high fat feeding. Diabetol Metab Syndr. Diabetology & Metabolic Syndrome; 2013; 5: 29.
87. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011; 13: 376-388. doi: 10.1016/j.cmet.2011.03.009 PMID: 21459323
88. Weng S-Y, Schuppan D. AMPK regulates macrophage polarization in adipose tissue inflammation and NASH. J Hepatol. 2013; 58: 619-21. doi: 10.1016/j.jhep.2012.09.031 PMID: 23046670
89. Bijland S, Mancini SJ, Salt IP. Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin Sci (Lond). 2013; 124: 491-507. doi: 10.1042/CS20120536
90. Seo MS, Kim JH, Kim HJ, Chang KC, Park SW. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes. Toxicol Appl Pharmacol. Elsevier B.V.; 2015; 284: 113-124. doi: 10.1016/j.taap.2015.02.020 PMID: 25737164